Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prion encephalopathies].

C Tranchant1, G Steinmetz, J M Warter

  • 1Service de Neurologie II, Hôpitaux universitaires, Strasbourg.

Revue Francaise De Transfusion Et D'Hemobiologie : Bulletin De La Societe Nationale De Transfusion Sanguine
|December 1, 1992
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Improvement of apathy in early Parkinson's disease.

NPJ Parkinson's disease·2025
Same author

French validation of the Quality of life in Essential Tremor Questionnaire (QUEST) and the Essential Tremor Embarrassment Assessment (ETEA).

Revue neurologique·2023
Same author

Early hyperdopaminergic state following sub-thalamic nucleus deep brain stimulation in Parkinson disease.

Revue neurologique·2022
Same author

Lack of pediatricians in sociomedical units (PASS) in France.

Archives de pediatrie : organe officiel de la Societe francaise de pediatrie·2022
Same author

Unravelling the etiology of sporadic late-onset cerebellar ataxia in a cohort of 205 patients: a prospective study.

Journal of neurology·2022
Same author

Validation of a non-motor fluctuations questionnaire in Parkinson's disease.

Revue neurologique·2021
Same journal

[Recombinant immunoglobulins].

Revue francaise de transfusion et d'hemobiologie : bulletin de la Societe nationale de transfusion sanguine·1993
Same journal

[HLA-DRB1 and HLA-DQB1 polymorphism in Algerians from Algiers].

Revue francaise de transfusion et d'hemobiologie : bulletin de la Societe nationale de transfusion sanguine·1993
Same journal

Comparative study of human monoclonal anti-D antibodies of IgG and IgM classes in tests with red cells of nonhuman primates.

Revue francaise de transfusion et d'hemobiologie : bulletin de la Societe nationale de transfusion sanguine·1993
Same journal

[A sickle cell homozygote with transfusion deadlock. Favorable outcome with hydroxyurea treatment].

Revue francaise de transfusion et d'hemobiologie : bulletin de la Societe nationale de transfusion sanguine·1993
Same journal

[The nomenclature of immunohematologic records:in favor of an evolution of biologic and medical practices].

Revue francaise de transfusion et d'hemobiologie : bulletin de la Societe nationale de transfusion sanguine·1993
Same journal

[Reduction of the post-transfusion hepatitis C risk in patients undergoing bone marrow allograft].

Revue francaise de transfusion et d'hemobiologie : bulletin de la Societe nationale de transfusion sanguine·1993
See all related articles

Spongiform encephalopathies, or prion diseases, affect the central nervous system in humans and animals. The exact cause is debated but may involve a modified prion protein, raising concerns about animal-to-human transmission.

Area of Science:

  • Neuroscience
  • Pathology
  • Infectious Diseases

Context:

  • Spongiform encephalopathies, including prion diseases, present distinct clinical and histological features.
  • These diseases are characterized by central nervous system degeneration and neuronal loss.
  • Transmissibility within species and between humans and animals is a key feature.

Purpose:

  • To review the characteristics of spongiform encephalopathies.
  • To discuss the potential nature of the prion protein as the causative agent.
  • To address concerns regarding the transmissibility of animal prion diseases to humans.

Summary:

  • Spongiform encephalopathies exhibit specific neurological symptoms, spongiform changes, and neuronal loss.
  • The pathogenic agent is hypothesized to be a modified prion protein, resistant to enzymatic degradation.

Related Experiment Videos

  • Recent bovine spongiform encephalopathy cases highlight the risk of zoonotic transmission.

    • Impact:

    • Understanding prion diseases is crucial for public health and veterinary medicine.
    • Further research into prion protein structure and function is needed.
    • This knowledge informs strategies for disease prevention and control, particularly concerning food safety.